Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology · 2025
[Comparison of therapeutic efficacy of treatment with hyperbaric oxygen versus a long intestinal tube for adhesive small bowel obstruction and paralytic ileus].
СтатьяСравнительное исследованиеАннотация на английскомНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Goto Shunya, Ohno Hideki, Ono Tatsunori, Ono Masafumi, Cho Kazumitsu
Аннотация
PURPOSE: Gastrointestinal cancer surgery is often complicated by adhesive small bowel obstruction (ASBO) and paralytic ileus (PI), managed with a long intestinal tube (LIT), surgery, or hyperbaric oxygen therapy (HBOT). LIT insertion is challenging for both patients and medical staff, whereas HBOT requires only bed rest. However, HBOT has not been reported in clinical practice. Therefore, this study aimed to investigate its use for postoperative ASBO in patients with gastrointestinal cancer.
METHODS: This single-center, retrospective study included gastrointestinal cancer patients with postoperative ASBO between January 2012 and March 2023. A total of 126 patients (mean age 77.3 years) diagnosed with ASBO or PI at our hospital were assigned to either HBOT (96 patients) or LIT (30 patients). The primary outcome was the fasting period. Responders were defined as cases that resolved with a single treatment.
RESULTS: The fasting periods did not differ significantly between the HBOT group (median [IQR], 5 [4-7] days) and the LIT group (5 [4-7.8] days;p=0.574). Among responders, the fasting period was also not significantly longer in the HBOT group (5 [3-7] days) than in the LIT group 5 [4-7.3] days;p=0.181). HBOT non-responders were significantly more emetic (94% vs 63%, p=0.018) and older (mean 82.0 vs 75.1 years;p=0.023) than HBOT responders.
CONCLUSION: HBOT appears no less effective than LIT for patients with ASBO or PI and offers greater comfort. It may be preferable for patients with mild vomiting, improvement after nasogastric tube placement, age <77 years, lower CRP, moderate intestinal dilatation, and within 24 hours of onset.
METHODS: This single-center, retrospective study included gastrointestinal cancer patients with postoperative ASBO between January 2012 and March 2023. A total of 126 patients (mean age 77.3 years) diagnosed with ASBO or PI at our hospital were assigned to either HBOT (96 patients) or LIT (30 patients). The primary outcome was the fasting period. Responders were defined as cases that resolved with a single treatment.
RESULTS: The fasting periods did not differ significantly between the HBOT group (median [IQR], 5 [4-7] days) and the LIT group (5 [4-7.8] days;p=0.574). Among responders, the fasting period was also not significantly longer in the HBOT group (5 [3-7] days) than in the LIT group 5 [4-7.3] days;p=0.181). HBOT non-responders were significantly more emetic (94% vs 63%, p=0.018) and older (mean 82.0 vs 75.1 years;p=0.023) than HBOT responders.
CONCLUSION: HBOT appears no less effective than LIT for patients with ASBO or PI and offers greater comfort. It may be preferable for patients with mild vomiting, improvement after nasogastric tube placement, age <77 years, lower CRP, moderate intestinal dilatation, and within 24 hours of onset.